Researchers hope psilocybin could improve quit rates for smokers
Alcoholism & Drug Abuse Weekly November 19, 2021 DOI: 10.1002/adaw.33270 via OpenAlex
Summary
AI-generated from the abstractNicotine is highly addictive, and current treatments for nicotine addiction achieve no better than a 30% success rate. A newly announced multisite study of the psychedelic psilocybin for smoking cessation is generating excitement. Those involved caution against overselling the potential but hope the large study with a diverse population will help identify who might benefit most from this alternative approach.
Study at a glance
| Characteristics | Multisite study Peer reviewed |
|---|---|
| Intervention | Psilocybin |
| Topics | Addiction Psilocybin |
| Keywords | Wonder Nicotine addiction Smoking cessation Psychology |
| Key finding | Current treatments for nicotine addiction have no better than a 30% success rate, and a new multisite study of psilocybin for smoking cessation is underway. |
Abstract
With nicotine being one of the most addictive substances and the available treatments for nicotine addiction leading to no better than a 30% success rate, it's no wonder that a newly announced multisite study of the psychedelic psilocybin for smoking cessation is generating excitement. While taking care not to oversell the potential of this strategy, those involved with the research hope at least that a large study with a diverse population will help identify who might eventually benefit most from the alternative approach.